Sarepta Therapeutics, Inc.

VANGUARD GROUP INC SRPT

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

11,810,729

Value ($000)

254,167

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	254,167	0.0%	11,810,729	12/31/2025
2025 Q3	11/7/2025	208,452	0.0%	10,817,446	9/30/2025
2025 Q2	8/11/2025	156,639	0.0%	9,160,179	6/30/2025
2025 Q1	5/9/2025	576,461	0.0%	9,032,613	3/31/2025
2024 Q4	2/11/2025	1,104,701	0.0%	9,085,456	12/31/2024
2024 Q3	11/13/2024	1,119,958	0.0%	8,967,552	9/30/2024
2024 Q2	8/13/2024	1,427,629	0.0%	9,035,624	6/30/2024
2024 Q1	5/10/2024	1,138,698	0.0%	8,795,754	3/31/2024
2023 Q4	3/11/2024	850,139	0.0%	8,816,124	12/31/2023
2023 Q3	12/18/2023	1,039,212	0.0%	8,572,944	9/30/2023
2023 Q2	8/14/2023	977,025	0.0%	8,531,479	6/30/2023
2023 Q1	7/14/2023	1,118,210	0.0%	8,112,964	3/31/2023
2022 Q4	2/10/2023	1,040,950	0.0%	8,033,264	12/31/2022
2022 Q3	11/14/2022	893,773	0.0%	8,085,517	9/30/2022
2022 Q2	8/12/2022	631,166	0.0%	8,420,047	6/30/2022
2022 Q1	5/13/2022	649,582	0.0%	8,315,182	3/31/2022
2021 Q4	2/14/2022	748,416	0.0%	8,311,108	12/31/2021
2021 Q3	11/12/2021	691,811	0.0%	7,480,651	9/30/2021
2021 Q2	8/13/2021	579,661	0.0%	7,456,402	6/30/2021
2021 Q1	5/14/2021	548,996	0.0%	7,366,100	3/31/2021
2020 Q4	2/12/2021	1,230,471	0.0%	7,217,258	12/31/2020
2020 Q3	11/16/2020	995,814	0.0%	7,091,182	9/30/2020
2020 Q2	8/14/2020	1,141,251	0.0%	7,117,697	6/30/2020
2020 Q1	5/15/2020	640,211	0.0%	6,544,789	3/31/2020
2019 Q4	2/14/2020	823,893	0.0%	6,384,788	12/31/2019
2014 Q2	8/11/2014	66,430	0.0%	2,229,951	6/30/2014
2014 Q1	5/13/2014	50,558	0.0%	2,103,931	3/31/2014
2013 Q4	2/12/2014	41,990	0.0%	2,061,338	12/31/2013